跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Cefaclor for Suspension
Approved
化学药品
Cefaclor for Suspension
Sun Pharmaceutical Industries Ltd
🇨🇳 National Medical Products Administration
Approval Date
Jan 15, 2024
Approval ID
8WeauCd1F1D
Company
Sun Pharmaceutical Industries Ltd
Type
化学药品
Approval Details
Approval Id
8WeauCd1F1D
Approval Number
国药准字HJ20150070
Generic Name
头孢克洛干混悬剂
Generic Name En
Cefaclor for Suspension
Trade Name
乐维
Drug Type
化学药品
Dosage Form
口服混悬剂
Strength
125mg/5ml(按C₁₅H₁₄ClN₃O₄S计算)
Reg Date
2024-01-15
Expired Date
2029-01-14
Company Name
Sun Pharmaceutical Industries Ltd
Production Company Name
Sun Pharmaceutical Industries Ltd
Company Detail Path
/organization/sun-pharmaceutical-industries-ltd
Production Company Detail Path
/organization/sun-pharmaceutical-industries-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 15, 2024
Approval ID
8WeauCd1F1D
Type
化学药品
Back to NMPA Approvals
乐维 - NMPA Drug Approval Details